AGATE ML LTD
Executive Summary
Agate ML Ltd operates as a micro-entity within the UK general medical practice sector, characterized by its small scale and limited financial resources. Its current financial position reflects typical challenges faced by small independent practices, including negative working capital and net liabilities, which constrain growth and operational resilience. Industry trends such as NHS contract consolidation and rising costs exacerbate these challenges, positioning the company as a niche, vulnerable player relative to more established competitors.
View Full Analysis Report →- Legal registered address
- 85 Great Portland Street First Floor London United Kingdom W1W 7LT Copied!
Latest financial results as of 8 October 2025- Current assets
- £13.19k
- Fixed assets
- £4.06k
- Current creditors
- £17.97k
- Shareholders funds
- £-727
View full financial accounts- Current assets
- £13.19k
- Fixed assets
- £4.06k
- Current creditors
- £17.97k
- Shareholders funds
- £-727
- Company number
- 14457859 Copied!
Accounts
Latest annual accounts were to 30 November 2024
Next annual accounts are due by 31 August 2026
Company financial year end is on 30 November 2025
Confirmation statement
Latest confirmation statement statement dated 1 November 2024
Next statement due by 15 November 2025
Nature of business (SIC)
86210 - General medical practice activities
Latest company documents
| Date | Description |
|---|---|
| 01/05/251 May 2025 | Micro company accounts made up to 2024-11-30 |
| 30/11/2430 November 2024 | Annual accounts for year ending 30 Nov 2024 |
| 01/11/241 November 2024 | Confirmation statement made on 2024-11-01 with no updates |
| 30/05/2430 May 2024 | Micro company accounts made up to 2023-11-30 |
| 30/11/2330 November 2023 | Annual accounts for year ending 30 Nov 2023 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company